ZUNHAYRE

Serial Number 98450533
Registration 7798467
700

Registration Progress

Application Filed
Mar 14, 2024
Under Examination
Approved for Publication
Apr 1, 2025
Published for Opposition
Apr 1, 2025
Registered
May 20, 2025

Trademark Image

ZUNHAYRE

Basic Information

Serial Number
98450533
Registration Number
7798467
Filing Date
March 14, 2024
Registration Date
May 20, 2025
Published for Opposition
April 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 20, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

Verona Pharma PLC

84
Address
One Central Square
Cardiff CF101FS
GB

Ownership History

Verona Pharma PLC

Original Applicant
84
Cardiff GB

Verona Pharma PLC

Owner at Publication
84
Cardiff GB

Verona Pharma PLC

Original Registrant
84
Cardiff GB

Legal Representation

Attorney
John Mueller

USPTO Deadlines

Next Deadline
1973 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250520)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
May 20, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 20, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 1, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 12, 2025 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 5, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 5, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Mar 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2025 ALIE A ASSIGNED TO LIE Loading...
Jan 14, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 21, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 21, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 21, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 19, 2024 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Mar 19, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Mar 14, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 042
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 044
Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Classification

International Classes
005 042 044